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Abstract
Purpose—Pain, dyspnea, and thirst are three of the most prevalent, intense, and distressing 
symptoms of intensive care unit (ICU) patients. In this report, the interdisciplinary Advisory Board 
of the Improving Palliative Care in the ICU(IPAL-ICU) Project brings together expertise in both 
critical care and palliative care along with current information to address challenges in assessment 
and management.
Methods—We conducted a comprehensive review of literature focusing on intensive care and 
palliative care research related to palliation of pain, dyspnea, and thirst.
Results—Evidence-based methods to assess pain are the enlarged 0–10 Numeric Rating Scale 
(NRS) for ICU patients able to self-report and the Critical Care Pain Observation Tool or Behavior 
Pain Scale for patients who cannot report symptoms verbally or non-verbally. The Respiratory 
Distress Observation Scale is the only known behavioral scale for assessment of dyspnea, and 
thirst is evaluated by patient self-report using an 0–10 NRS. Opioids remain the mainstay for pain 
management, and all available intravenous opioids, when titrated to similar pain intensity end 
points, are equally effective. Dyspnea is treated (with or without invasive or noninvasive 
mechanical ventilation) by optimizing the underlying etiological condition, patient positioning 
and, sometimes, supplemental oxygen. Several oral interventions are recommended to alleviate 
thirst. Systematized improvement efforts addressing symptom management and assessment can be 
implemented in ICUs.
Conclusions—Relief of symptom distress is a key component of critical care for all ICU 
patients, regardless of condition or prognosis. Evidence-based approaches for assessment and 
treatment together with well-designed work systems can help ensure comfort and related favorable 
outcomes for the critically ill.
Keywords
Pain; Dyspnea; Thirst; Palliation
Introduction
Critical illness and its management in the intensive care unit (ICU) present special 
challenges for control of pain and other symptoms that cause patient distress. Many patients 
cannot provide self-reports, the gold standard of symptom information, in real time. 
Interventions used to diagnose and treat critical illness are themselves common sources of 
symptom distress, as are routine and noninvasive aspects of patient care such as turning. 
Treatments to relieve symptoms must take account of the complex pharmacologic and 
physiologic issues that accompany multiple organ failures. At the same time, relief of 
symptom distress is a foundational aspect of palliative care, which is an integral component 
of comprehensive critical care for all ICU patients, from the time of admission, regardless of 
prognosis [1, 2]. Evidence-based strategies for symptom assessment and management can 
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not only promote patient comfort in the ICU but help modulate the stress response, with 
potential physiologic benefits [3–5]. When knowledge and skill are applied in a systematic 
effort, symptom relief can be fully consistent with restorative treatment of critical illness [6].
Expert guidelines are available to assist in the management of pain [7] and dyspnea [8, 9], 
but additional empirical evidence to support clinical care is needed, and wide variation in 
practice is common. Meanwhile, the high prevalence, frequency, and intensity of other 
distressing physical symptoms, such as thirst, and psychological symptoms, have come into 
clearer view recently, but without development and rigorous testing of palliative 
interventions. The Improving Palliative Care in the ICU (IPAL-ICU) Project, sponsored by 
the National Institutes of Health and the Center to Advance Palliative Care, shares technical 
assistance, evidence, and tools to integrate palliative care and intensive care successfully 
from the onset of critical illness for all ICU patients, including those pursuing intensive 
therapies to prolong life and restore baseline health. In this review, the interdisciplinary 
IPAL-ICU Advisory Board brings together the combined expertise of its members in 
palliative care and intensive care to address challenges in assessment and management of 
pain, dyspnea, and thirst during critical illness. We focus on the following questions: (1) 
What are key elements necessary to assess these three common symptoms in the ICU? (2) 
What are optimal strategies for managing these symptoms during critical illness? (3) How 
can symptom care be systematized for improvement?
What are the most prevalent and distressing symptoms experienced by 
critically ill patients?
Over a period spanning two decades, studies conducted in various ICU settings confirm that 
pain, dyspnea, and thirst are among the most prevalent and distressing physical symptoms 
experienced by critically ill patients who can provide a symptom self-report. In a survey 
from the early 1990s, 70 % of patients recalled pain (rated as moderate or severe by 63 %) 
during treatment in medical and surgical ICUs [10]. Findings of a more recent study [11] 
were strikingly similar: 77 % of patients transferred from cardiac surgery ICUs recalled 
pain, and 64 % of them rated the pain as moderate or severe. In a study of critically ill 
cancer patients receiving ICU care, 56 % of those who could self-report symptoms 
experienced moderate or severe pain, while 34 and 71 % reported dyspnea and unsatisfied 
thirst, respectively, at these levels [12]. In another recent study, more than 400 interviews 
with 171 critically ill patients at high risk of dying revealed pain in 40 %, dyspnea in 44 %, 
and thirst in 71 % of these assessments [13]. A study focusing on patients receiving 
mechanical ventilation showed that almost half of patients experienced dyspnea, which was 
significantly associated with anxiety [14]. The contribution of diagnostic and treatment-
related procedures to pain and other suffering in the ICU has been demonstrated in major 
studies in the USA and elsewhere. Evaluating more than 6,000 patients in 167 ICUs, the 
Thunder Project II® examined the painfulness of turning, tracheal suctioning, non-burn 
wound care, wound drain removal, central line insertion, and femoral sheath removal [15]. 
The most painful procedure for adults was turning. Post-cardiac and abdominal surgery ICU 
patients reported moderate to severe pain associated with endotracheal (ET) suctioning 
and/or chest tube removal [16]. Moderate to severe pain has been reported by over 30 % of 
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cancer patients who underwent the following ICU procedures: ET suctioning, turning, 
arterial blood gas puncture, arterial catheter insertion, central catheter insertion, or 
peripheral intravenous (IV) insertion [12]. The symptom experience of cognitively impaired 
patients is less well understood [17].
What are key elements necessary to assess symptoms in the ICU?
The cornerstone of effective symptom control is systematic symptom assessment. Ideally, 
symptoms are reported and rated by patients themselves, using a tool that is sufficiently 
simple and brief while providing adequate information for clinical use. Below is a summary 
of approaches for ICU patients who can report their symptoms, either verbally or non-
verbally, and for non-communicative patients.
Assessment approaches for communicative patients
Table 1 presents symptom assessment tools for use with ICU patients who can communicate 
verbally (by stating their answers) or non-verbally (by pointing to numbers or words that 
rate or describe their pain or by pointing to a body outline diagram to localize their pain). 
Owing to its simplicity, a 0–10 Numeric Rating Scale (NRS), with anchor words at each end 
that identify extremes of severity, is recommended for assessing dyspnea in patients with 
advanced illness [18]. The NRS has also been used frequently to measure the intensity and 
distress of pain [15, 19, 20] and thirst/dry mouth [21]; patients can say or point to a number 
that approximates symptom severity. A 0–10 visually enlarged, horizontal NRS was found to 
be the most valid and feasible of five pain intensity rating scales tested in over 100 self-
reporting ICU patients [22]. A vertical visual analog scale (VAS) was preferred by patients 
over a horizontal VAS for reporting dyspnea [23]. Like an NRS, a VAS allows for 
measurement of symptom severity but the VAS is difficult for many patients in the ICU to 
understand and use.
The Condensed Form of the Memorial Symptom Assessment Scale [24] and the Edmonton 
Symptom Assessment Scale [25] are tools that allow for verbal or non-verbal patient reports 
by which a diverse group of physical symptoms including pain and dyspnea as well as 
psychological symptoms can be measured. Recently, a 10-item multi-symptom scale was 
validated in a large group of self-reporting ICU patients [13]. Clinicians can provide patients 
opportunities to report symptoms by having them point to one of these short symptom word 
lists or helping them to localize their pain by offering body outline diagrams and asking 
patients to point to the place(s) where they are feeling pain [19]. Speech language 
pathologists can help augment the patient’s ability to communicate and to assist 
communication through alternative approaches [26]. Such strategies include alphabet and 
number boards, electronic speech-generating devices, or a touch screen requiring minimal 
physical pressure to activate message buttons.
Assessment approaches for non-communicative patients
Three approaches have been used to help understand the experience of patients who cannot 
report their symptoms verbally or non-verbally: (1) behavioral assessment; (2) proxy 
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assessment; and (3) presumption of symptom distress in situations in which communicative 
patients typically report such distress.
Behavioral symptom assessment—Important advances have been made in 
development of pain assessment tools based on patient behaviors. The Behavior Pain Scale 
(BPS) [27] and the Critical Care Pain Observation Tool (CPOT) [28] have good 
psychometric properties and are recommended for use with adult ICU patients excluding 
those with brain injuries [7]. All such tools must be used cautiously, since the findings are an 
indirect representation of a patient’s perceptual experience. Investigators validated specific 
procedure-related pain behaviors in a large study of procedural pain, with the most frequent 
being grimacing, rigidity, wincing, shutting of eyes, verbalization, moaning, and clenching 
of fists [29].
The Respiratory Distress Observation Scale (RDOS) is the only known behavioral scale for 
assessment of dyspnea. RDOS includes eight observer-rated parameters: heart rate, 
respiratory rate, accessory muscle use, paradoxical breathing pattern, restlessness, grunting 
at end-expiration, nasal flaring, and a fearful facial display. Each parameter is scored on an 
ordinal scale from 0 to 2 points and the points are summed. Behavior variables that comprise 
the RDOS were identified from videotaping mechanically ventilated patients undergoing a 
failed ventilator weaning trial and experiencing dyspnea [30]. Construct, convergent, and 
discriminant validity have been demonstrated for this tool, as have internal consistency and 
inter-rater reliability [31, 32].
Proxy symptom assessment—The use of symptom reports from surrogates, such as 
family members, or bedside clinicians, remains controversial. In some studies, patients rank 
their symptoms higher than proxy reporters [33, 34], while in other reports the opposite is 
true [35, 36]. Recently, the agreement between ICU patients and their family members on 
the distress of patient pain, dyspnea, restlessness, fear, and thirst was demonstrated to be 
moderately strong [37]. Overall, data suggest that proxy reporters can help identify 
symptoms that might be distressing for the patient. In addition, although evidence remains 
limited, proxy data may be useful for trending symptom distress over time.
Assume symptom presence under certain circumstances—When patients are 
unable to self-report, and unable to demonstrate symptom-related behaviors (such as when 
chemically paralyzed), clinicians can use their experience and judgment to identify possible 
sources of symptom distress. The assumption that the patient is experiencing distress from 
pain, thirst, or dyspnea given the surrounding circumstances may lead clinicians to further 
attempts to determine the presence of the symptom and address it appropriately. An 
analgesic trial, starting with a low dose fast-acting opioid (e.g., fentanyl), followed by 
observation of the patient for pain-related behaviors, may help to verify the presence of pain 
[38, 39]. If behaviors indicating pain persist and no other cause for the behaviors has been 
identified, the initial dose can be increased. Alternatively, if pain-related behaviors seem to 
decrease in response to the analgesic, further interventions, such as scheduled analgesic 
dosing, can be planned. The same approach can be applied to observed respiratory distress 
using opioids.
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What are current strategies for managing symptoms during critical illness?
Pain
Treatments to relieve symptoms must take into account the complex pharmacologic and 
physiologic issues that accompany multiple organ failures. Concerns about secondary effects 
of certain treatments, including hypotension, sedation, respiratory depression, delirium, and 
other alterations of consciousness, further complicate patient management.
Opioids remain the primary medications to manage pain in ICU patients [40]. Recent 
guidelines from the Society of Critical Care Medicine (SCCM) [7] recommend 
intravenously administered opioids as the drug class of choice to treat non-neuropathic pain 
in critically ill patients. These guidelines note that all available intravenously administered 
opioids, when titrated to similar pain intensity end points, are equally effective, and the 
optimal choice of opioid and the dosing regimen used for an individual patient depend on 
many factors including age, underlying comorbidities/end-organ function, and the chosen 
opioid’s pharmacokinetic and pharmacodynamic properties. Although some opioid side 
effects (e.g., sedation) tend to abate with continued treatment, constipation is the most 
common persistent side effect. Thus, except in the face of bowel obstruction, diarrhea, or 
another contraindication, a bowel regimen with a stimulant (e.g., senna) or osmotic (e.g., 
lactulose) laxative must be prescribed when sustained opioid dosing is initiated. Tracking 
bowel function is a basic component of ICU monitoring. Table 2 summarizes key elements 
of using opioids for critically ill patients.
Non-opioid analgesics can be used in the ICU including orally or intravenously administered 
acetaminophen [41]; intravenously administered ketamine [42]; intravenously administered 
nefopam [43, 44] (thought to inhibit reuptake of dopamine, norepinephrine, and serotonin; 
used primarily in Europe); and orally, intravenously, and rectally administered 
cyclooxygenase inhibitors [45], although the last of these are limited by their side effect 
profile. Use of these medications in conjunction with opioids may decrease the overall 
quantity of opioids administered and the incidence and severity of opioid-related side effects 
[7]. All non-opioid analgesics should be used with caution because of drug-specific 
toxicities that may affect end-organ function [46]. For patients with neuropathic pain, 
gabapentin and carbamazepine can be considered [47, 48]. Both are categorized as 
antiepileptic and antihyperalgesic drugs, and both have been tested in ICU patients. Newer 
drugs for neuropathic pain such as pregabalin, lamictal, trileptal, duloxetine, and venlafaxine 
require further testing during critical illness. Intravenously administered acetaminophen is 
now approved for use in the USA. Its safety and effectiveness as an adjunct to opioids have 
been demonstrated in ICU patients after major general [41] and cardiac surgery, but it may 
not be necessary unless enteral administration is contraindicated [49]. Ketamine, an 
anesthetic and analgesic agent, has been used in ICU patients to help prevent or reduce 
opioid tolerance and to provide pain relief, especially when pain is refractory to opioids and 
other agents [50, 51]. Ketamine is an N-methyl-D-aspartate/glutamate receptor (NMDA) 
antagonist that interferes with the normal excitatory effects of glutamate and aspartate and 
also interacts with opioid receptors [51]. Sub-anesthetic doses of ketamine can be 
administered with opioids to help reduce the overall opioid dose [51]. With or without 
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coadministration of opioids, patients receiving ketamine may experience psychotomimetic 
side effects (dysphoria, nightmares, hallucinations), especially at higher ketamine doses. 
There is limited research on the efficacy of regional anesthetics in ICU patients, although 
thoracic epidural anaesthesia/analgesia is recommended by the American College of Critical 
Care Medicine for consideration for postoperative pain in patients undergoing abdominal 
aortic surgery [7].
Treating pain in the presence of physiologic instability is an ongoing concern of ICU 
clinicians. Fears of hypotension, respiratory depression, sedation, and addiction are often 
exaggerated but may lead to physician reluctance to prescribe appropriate analgesia and to 
administration of suboptimal doses by nurses [52–55]. Clinicians should not allow pain or 
other distressing symptoms to persist as a way to help maintain blood pressure and/or 
stimulate respiratory effort. Clinicians should use all ICU resources (interdisciplinary team 
along with patient and family input) and seek consultative advice if necessary to find an 
appropriate combination of symptom relief and physiologic stability in the context of the 
patient’s goals of care [5]. Preventing pain could actually be associated with better control of 
the acute stress response in patients which could, in turn, increase physiological stability.
Non-pharmacologic interventions for pain management, such as massage, music therapy, 
and relaxation techniques, cost little and are safe and easy to provide. However, the 
effectiveness of non-pharmacologic interventions for pain in ICU patients is not yet clearly 
established by empirical evidence [46, 56].
More than a decade ago, guidelines were published for management of acute and procedure-
related pain [57]. Simple pharmacologic and non-pharmacologic interventions exist to 
decrease such pain. Still, few patients undergoing procedures receive a specific intervention 
for procedural pain [40]. ICU clinicians should be prepared to premedicate even for 
procedures that can be completed quickly, such as chest tube or sheath removal, or for 
routine procedures (such as turning or bathing) that are painful for many patients. Opioids 
and/or non-opioids with rapid onset and offset, augmented by relaxation, visualization, or 
other techniques, can be used to prevent or decrease procedural pain.
Dyspnea
Dyspnea is treated by optimizing the underlying etiological condition, such as with inotropes 
and diuretics for heart failure, along with drug and non-drug treatments. Mechanical 
ventilation, invasive or noninvasive, can reduce dyspnea from respiratory failure, but may 
not be appropriate for some patients in light of risks and burdens to the patient, and some 
mechanically ventilated patients experience dyspnea [14]. The use of noninvasive ventilation 
(NIV) for symptom palliation in patients forgoing invasive mechanical ventilation was 
addressed by a task force of the SCCM [58]. Although NIV can be an effective treatment for 
acute respiratory failure associated with exacerbation of obstructive lung disease, 
cardiogenic pulmonary edema, neuromuscular disease, and certain other conditions, 
effectiveness for relief of dyspnea is less well established. NIV was more effective than 
oxygen in reducing dyspnea and the need for morphine in a study of patients with solid 
tumors and respiratory failure, particularly those with hypercarbia; however, NIV was 
discontinued in 7 % of the study group owing to patient intolerance [59]. In a descriptive 
Puntillo et al. Page 7
Intensive Care Med. Author manuscript; available in PMC 2017 May 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
study of other outcomes of NIV in patients with do-not-intubate directives, dyspnea was not 
measured; 10 % of these patients requested discontinuation of NIV and 76 % experienced 
disruption of sleep quality, as evaluated by nurses [60, 61]. As stated by the SCCM’s task 
force, the appropriate end point for use of NIV with a critically ill patient whose treatment is 
focused exclusively on comfort is symptom relief, while failure to improve or distress 
warrant discontinuation of NIV [58]. Some patients will not want to undergo any form of 
mechanical ventilation and the treatment of dyspnea will rely on drug and non-drug 
treatments (see Table 3).
Positioning can be an important non-pharmacologic treatment. For example, dyspnea in 
COPD can be reduced by upright positioning with arms elevated on pillows or a bedside 
table [62, 63]. In unilateral lung disease a sidelying position may be optimal, with the 
“good” lung up or down to increase perfusion and/or ventilation. Using the patient as his/her 
own control and measuring dyspnea or respiratory distress in various positions will help to 
identify the best position. Patient activity, whether active or passive, increases oxygen 
consumption that may lead to dyspnea. Since nurses coordinate most patient care in the ICU, 
their input is essential in determining timing of activity to minimize or prevent dyspnea.
Oxygen is considered standard therapy for dyspnea in patients with hypoxemia [64, 65], but 
robust data are lacking and no predictable relationship has been found between the degree of 
hypoxemia and the symptomatic response to supplemental oxygen [66, 67]. No benefit from 
oxygen compared to medical air was found in a study of patients with advanced lung disease 
who were not hypoxemic [68]. Patients who were near death and at risk for dyspnea 
remained comfortable without oxygen [69]. A fan directed at the patient’s face may provide 
relief [70], although use in the ICU may be limited by bioengineering restrictions.
Opioids are the mainstay of pharmacological management of dyspnea that is refractory to 
disease-modifying and/or non-pharmacologic symptom treatment, and their effectiveness 
has been demonstrated in numerous clinical trials [54, 55]. The doses of opioids for acute 
dyspnea exacerbations are less well known than those used to treat acute pain. “Low and 
slow” intravenous titration of an immediate-release opioid, repeated every 15 min, should be 
provided until the patient reports or displays relief. Around the clock dosing may be best if 
the patient has dyspnea continuously or at rest, but with pro re nata (prn) dosing for episodic 
dyspnea [71]. Benzodiazepines have not generally been effective as a primary treatment for 
dyspnea [72]. The addition of an adjunctive benzodiazepine to the opioid regimen has been 
successful in patients with advanced COPD [73, 74]. As with opioids, these agents should be 
titrated to effect.
Thirst and xerostomia
Several methods of alleviating thirst and xerostomia (dry mouth) have been identified. 
Topical products that contain olive oil, betaine, and xylitol, artificial saliva, and salivary flow 
stimulants have been effective [75]. The effectiveness of frozen gauze pads with normal 
saline, wet gauze, or ice was documented in post-laparoscopic cholecystectomy patients 
[76]; patients receiving frozen gauze or ice reported significantly less thirst than patients 
receiving wet gauze pads. These interventions have not been specifically tested in ICU 
patients. A randomized trial was recently completed in ICU patients to test the effects of 
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sprays of cold sterile water, swabs of cold sterile water, and use of a mouth and lip 
moisturizer [21]. This “bundle” of thirst interventions significantly decreased thirst intensity 
and distress in a group of ICU patients when compared to patients who did not receive the 
intervention. Use of lemon–glycerin swabs is not recommended because they produce an 
acid pH [77], dry oral tissues [78], cause irreversible enamel softening and erosion [79], and 
exhaust salivary mechanisms over time, leading to increased xerostomia [80]. For non-
intubated patients receiving high flow oxygen therapy, the use of heated humidifiers versus 
bubble humidifiers significantly lowered mouth and throat dryness [81]. Table 4 provides a 
summary of key steps to assess and manage thirst in the ICU patient.
Incorporating family members in symptom management
Family members may want to participate in providing symptom care as a way of feeling 
connected to their critically ill loved one. Most family members want to be with the patient 
[82] and to know about the patient’s condition and treatments [83]; patients value this [1]. 
Some seek directions as to what they can do at the bedside [83]. In a survey of 20 relatives 
and 27 ICU nurses [84], a high proportion of both agreed that families can be involved in 
physical care of the patient including mouth and eye care, bed bathing, turning, and 
positioning the patient. ICU family members have identified themselves as providing care to 
their loved ones including massaging, repositioning, distracting, and assisting with activities 
of daily living [85]. Thus, family members can be queried about their interest in assisting 
with pain, dyspnea, and thirst-relieving measures. For example, they might assist in 
evaluating patients’ responses to procedures and activities that can cause pain (such as 
turning, suctioning, and mobilization) [15] and report their observations to the ICU team. 
They might help the patient find an optimal position and use a fan that reduces dyspnea. 
Family members could provide simple mouth care and/or ice chips to relieve thirst if not 
contraindicated. While not all family members want to provide direct care [86], inclusion of 
interested families in providing patient care can have positive effects for patients and family 
members alike. Family members who were invited to provide care were almost twice as 
likely to perceive more respect, increased collaboration, greater support, and higher overall 
family-centered care (ORs 1.6–1.9) from ICU staff than control group families [87].
Involvement of palliative care specialists in symptom management
Specialist palliative care consultation is a consideration when the patient’s symptoms are 
difficult to manage, no matter what the diagnosis or prognosis. For example, patients who 
require high doses of opioids pose a challenge for ICU clinicians who may have little 
experience with complex and escalating dosing regimens or side effect management. 
Choosing optimal primary and adjunctive therapies in the context of liver or renal failure is 
another example of symptom care that may be enhanced by specialist palliative care 
consultation.
How can symptom care be systematized for improvement?
The SCCM has published clinical practice guidelines based on best available evidence for 
pain, agitation, and delirium [7]. Yet, as the SCCM acknowledged, “closing the gap between 
the evidence highlighted in these guidelines and ICU practice will be a significant challenge 
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for ICU clinicians and is best accomplished using a multifaceted, interdisciplinary 
approach” [7]. In some ICUs, structured approaches have been used with success to improve 
pain assessment and treatment [6, 88, 89]. For example, one ICU [89] tested a group of 
interventions to improve pain: (1) clinician education on the importance of standardizing 
methods of pain evaluation and treatment; (2) incorporation in every bedside medical record 
of a VAS for pain assessment; (3) implementation of house staff reporting of pain scores on 
daily ICU rounds; (4) interdisciplinary collaboration to develop a plan of care when pain 
scores above a specified threshold indicated an adverse event comparable to a medication 
error. The percentage of 4-h patient–nurse intervals in which nurses documented pain scores 
increased from 42 to 71 %, and the percentage of pain scores 3 or less on a scale from 0 (no 
pain) to 10 (maximum pain) increased from 59 to 97 %. The investigators emphasized the 
contribution of the ICU staff to the development of the specific interventions, the simplicity 
and feasibility of these interventions, the attention to work process efficiency (specifically, 
making the pain assessment tools consistently available at the bedside), the accountability 
provided by continuing measurement and feedback of performance, and the attitudinal shift 
about analgesic practice that was fostered across the ICU team.
In another study [6], nurses reported pain assessments on daily rounds with physicians, and 
alerted the physician promptly when a patient’s pain or agitation exceeded specified levels. 
Attending physicians, house officers, and nurses received verbal and written educational 
materials, such as pocket cards with assessment scales, and a laminated poster of the pain 
scale was placed on the wall of each patient room. After implementation, the investigators 
observed significant decreases in the incidence of pain (63 to 42 %) and agitation (29 to 
12 %) along with a decrease in reports of severe pain and agitation. The duration of 
mechanical ventilation and rate of nosocomial infections were both significantly reduced in 
the intervention group, and the proportion of nurses who were satisfied with the 
management of pain and sedation was dramatically increased. Although focused primarily 
on symptom assessment, the interdisciplinary approach of this initiative appeared to enhance 
the timeliness of physicians’ responses and allowed closer titration of analgesics and 
sedatives, including both increases and decreases in dosing, based on improvements in the 
nurses’ assessments.
An improvement effort addressing symptom management and assessment can be organized 
in the same way that has been recommended for improving ICU palliative care and other 
areas of critical care practice [81, 82, 90]. Key elements, which we have previously 
described [90], are set forth in Table 5. Success in achieving organizational change is more 
likely if supported by “champions”, who ideally are individuals with authority and respect in 
the ICU and institution. At the same time, enduring change appears to depend on design of 
work systems and processes that facilitate delivery of high-quality care [52, 91]. Examples 
include the use of “preprinted and/or computerized protocols and order forms, and quality 
ICU rounds checklists to facilitate the use of pain…management guidelines…”, as recently 
recommended by SCCM and others [52, 92]. As another example that is analogous to use of 
preoperative “time outs” to promote safety, a protocol for an invasive procedure could 
require that both the nurse and physician agree on the adequacy of preemptive analgesia 
before proceeding. The regular agenda for rounds might be modified to begin with 
presentation of symptom scores and related issues [6], such as the targeted level of symptom 
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control, with documentation on a daily goals sheet [93]. If a palliative care consultant or 
service is available in the hospital, the ICU might implement a screen to identify patients 
with complex or refractory symptom issues who could benefit from specialist input [94]. 
Inclusion of all disciplines in development of system and process supports is necessary. 
Shadowing of clinicians during symptom assessment and management processes can help 
identify obstacles and suggest steps to a more efficient and effective process [95].
Measuring quality of care
In parallel with processes of care designed to improve symptom assessment and 
management, data should be captured to assess the quality of care. Specified measures are 
available to evaluate the quality of care related to pain and dyspnea in the ICU (see Table 6). 
For example, the National Quality Measures Clearinghouse of the Agency for Healthcare 
Research and Quality posted measures 0 [2] focusing on the proportion of 4-h nurse–patient 
care intervals in which pain is assessed. Measures of respiratory distress were proposed on 
the basis of literature review and expert consensus by the Robert Wood Johnson Foundation 
Critical Care Peer Workgroup [96]. A consensus of experts convened by the American 
College of Chest Physicians recommended periodic review of patient and family satisfaction 
with symptom treatment, “bearing in mind that patients often report satisfaction with pain 
treatment despite experiencing severe pain, a high incidence of side effects, and inadequate 
pain treatment” [52]. This expert group also recommended surveying physicians and nurses 
for satisfaction to provide insight into aspects of care warranting further change. In choosing 
measures, ICUs should carefully consider feasibility of data collection, since few units will 
have resources for a complex or large-scale measurement effort, and most will have other 
improvement projects that compete for resource allocation. To reduce burden in their project 
to improve pain assessment and management, leaders in one ICU [89] limited data collection 
to a random subset of ICU patients at selected intervals. In addition, while ongoing 
evaluation is an essential component, measurement alone will not improve care but must be 
coupled with well-designed interventions to achieve better performance [97]. Finally, it is 
important to monitor for the emergence of unintended adverse effects of new processes of 
care [89], such as an unacceptable burden on staff, or an increase in duration of mechanical 
ventilation, alterations in patient mental status, or constipation, that might be thought to 
result from changes in symptom strategies.
Conclusion
An important goal for improving ICU palliative care is to not only promote patient comfort 
but to support other favorable outcomes of intensive care that are associated with symptom 
control. Pain, dyspnea, and thirst are prevalent symptoms that produce patient distress. We 
offer valid and reliable symptom assessment methods to meet the specific communication 
and cognitive abilities of critically ill patients in order to gain as much knowledge as 
possible of the patient’s experience. Treatment of pain, dyspnea, and thirst entails an array of 
techniques that must be appropriate to the source, or anticipated source, of the symptom, the 
condition of the patient, and the goals of care. The concerted, collaborative efforts of the 
entire ICU clinical team—physicians, nurses, and therapists— aided by input and support 
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from patients and families will help close the gap between evidence and practice for treating 
distressing symptoms.
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Table 1
Symptom assessment scales and their feasibility for self-reporting ICU patients
Type of instrument Description Comments
Self-report—unidimensional
pain, thirst, or dyspnea scale
0–10 numeric rating scale (NRS) Higher numbers indicate greater pain (or dyspnea, or
thirst) intensity. Example: 0 = no pain and
10 = worst possible pain. NRS has both construct
[98, 99] and concurrent validity [98, 100]
A 0–10 horizontal, visually enlarged laminated NRS for
pain is most feasible and valid for ICU patients [22]
Self-report—unidimensional
pain or dyspnea scale
0–10 cm visual analog scale (VAS) A 10-cm line, with anchors at either end. Example: one
end is marked “no pain” and the other end is marked
“pain as bad as it could be” or “the worst imaginable
pain”. The patient makes a vertical line through the
horizontal 10-cm line to indicate his or her pain
intensity. The clinician then measures from the left of
the horizontal line to the patient’s vertical line with a
ruler and assigns a score. Difficult for many patients
to understand and use
Self-report body outline
diagram pain scale
Identifies pain location. Diagram of front
and back of a “neutral” body divided
into body sections
Patient is able to point to, or mark, the place or places on
the diagram where pain is felt. Has been used with
ICU patients [19]
Self-report—multidimensional
pain scale
McGill Pain Questionnaire-Short Form
(MPQ-SF)
Scale with 11 sensory (such as sharp or throbbing) and
four affective (such as fearful or sickening) words.
MPQ-SF also has a VAS and a verbal scale. The
15-word scale has been used in ICU patients [19]
Self-report—multiple
symptoms scale
Condensed Form of the Memorial
Symptom Assessment Scale—MSAS
[24]
Measures a diverse group of symptoms. Has been used
with critically ill patients [101]
Self-report—multiple
symptoms scale
Edmonton Symptom Assessment Scale
[25]
Measures a diverse group of symptoms. Has been used
with critically ill patients [12]
Self-report—multiple
symptoms scale
10-item symptom assessment scale Modification of MSAS and Edmonton. Validated in ICU
patients [13]
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Table 2
Key elements of opioid use for ICU patients
Element Key point
Opioid dosing ICU clinicians responsible for pain management should have knowledge of equianalgesic opioid dosing
Dosing regimens should be based on a risks/benefits ratio for an individual patient [46]
There is no maximum dose or duration of effect; these must be individualized [46]
The “normal dose” for an individual patient is that which adequately relieves pain without unacceptable adverse
effects [51]
Opioid administration The preferred mode of initial therapy is rapid titration of opioids with small incremental IV doses [46]
Both remifentanil and sufentanil can be considered for use since both are short-acting opioids and may decrease
the duration of mechanical ventilation and ICU length of stay [102] and improve procedural pain management
[103]
Dose and rate-related histamine release does not occur with fentanyl analogues and can be limited by slowing
the rate of IV administration of opioids [46]
Methadone has unpredictable pharmacokinetics and pharmacodynamics in opiate-naïve patients. The patient’s
Q–T interval (corrected) of the electrocardiographic tracing should be monitored carefully if methadone is
used at all [46]
Opioids–other
considerations
It is necessary to institute a bowel regimen with stimulant or osmotic laxative in all patients receiving sustained
opioid administration unless there are contraindications such as small bowel obstruction [46]
Use of opioids in liver failure can be complicated since most opioids are at least partially metabolized in the
liver, reducing opioid clearance. Fentanyl may be preferred opioid in liver failure although its half-life is
prolonged with repeated dosing or use of high doses. Use opioids cautiously in patient with end-stage liver
disease. Longer dosing intervals may be needed [104]
Use of opioids in renal failure is associated with complex drug absorption, metabolism, and renal clearance.
Meperidine has been removed from many hospital formularies and, even if available, potential toxicity
contraindicates its use in renal failure. Use of codeine and morphine is not recommended. Hydromorphone
should be used cautiously; an active metabolite can accumulate between dialysis treatments. Fentanyl and
methadone are relatively safe in renal failure since they have no active metabolites. However, neither is
removed by dialysis [105]
Opioids, especially when used chronically or in patients with renal failure, electrolyte disturbances, and
dehydration, may cause neuroexcitatory effects, such as myoclonus [106]. Myoclonus may resolve over a few
days with decrease in opioid dose. Myoclonus, especially if mild, should not interfere with good pain control.
Rotating opioid to a lower dose of another opioid with a different structure may reduce myoclonus within
24 h. Fentanyl might be a better choice in this case since it has no active metabolites [107]
Certain opioids such as fentanyl distribute in fat which can prolong the opioid effects
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Table 3
Dyspnea interventions, mode of action, and rationale
Intervention Dose Mode of action Rationale
Optimal positioning, usually
upright with arms elevated and
supported [62, 63]
Whenever patient reports dyspnea
or displays respiratory distress
Increases pulmonary volume
capacity
Increases air exchange which
may improve oxygenation
and carbon dioxide
clearance and reduce
inspiratory effort
Balance rest with activity
Space nursing care
Guided by dyspnea/respiratory
distress
Decreases excessive oxygen
consumption
Prevents hypoxemia
Oxygen as indicated by goals of
therapy; not useful in
normoxemia or when the patient
is near death and in no distress
[8, 68, 69]
Variable, guided by goals of
therapy and patient
characteristics
Improves the partial pressure of
oxygen; reduces lactic
acidemia
Treats hypoxemia
Cold cloth on face [108] As needed Trigeminal nerve stimulation;
action on dyspnea unknown
Anecdotal reports of patient
relief; inexpensive; easy to
perform
Opioids, such as morphine or
fentanyl [54]
Low doses titrated to the patient’s
report of dyspnea or display of
dyspnea behaviors is effective;
oral or parenteral; no evidence to
support inhaled administration;
no evidence on dosing regimens
Uncertain direct effect;
reduced brainstem sensitivity
to oxygen and carbon
dioxide; altered central
nervous perception
Strong evidence-base supports
effectiveness
Benzodiazepines, such as
lorazepam or midazolam [73]
Low doses titrated to the patient’s
report of dyspnea or display of
dyspnea behaviors; no evidence
for benzodiazepine regimens
Anxiolysis Fear or anxiety often
accompanies dyspnea
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Table 4
Key steps to assess and manage thirst in ICU patients
1 Conduct regular thirst assessments in patients able to self-report
2 Examine the mouth and tongue for dryness and cracking or infection, as indicators of thirst/dryness
3 Recognize the risk profile for patient thirst including NPO status, and administration of anticholinergic medications and opioids
4 Assume that the patient is experiencing thirst
5 Do frequent mouth care
6 Use water-soaked gauzes, water sprays, and ice chips frequently when permissible
7 Consider the use of artificial saliva
8 Consider the use of heated humidifiers in patients with high-flow oxygen therapy
9 Evaluate and document the effectiveness of the thirst interventions
NPO nil per os
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Table 5
Key steps for organizing a symptom improvement initiative
Convene a project workgroup
• Include representatives of stakeholder groups
—e.g., ICU physician director, ICU nurse manager, nursing educator, pharmacist, palliative care clinician if available
• Engage hospital leadership if possible
• Meet at least every other week
Define the problem
• Assess existing practices to identify opportunities and priorities for improvement
—e.g., Review patients’ symptom ratings, HCAHPS survey responses, frequency of symptom assessment by staff, use of 
specific medications, assessment/management of side effects of symptom treatment (e.g., constipation)
• Identify available resources to support the improvement effort
—e.g., Pharmacy, quality monitoring staff, personnel, educational staff
Prepare an action plan
• Determine an aim that is specific, achievable, and time-bound
—e.g., By 6 months from start, ≤X % of patients will have ≥Y pain ratings above mild level
• Identify changes in clinical practice and systems that can help achieve the desired aim
—e.g., Standardize assessment tools for patients who can and cannot self-report symptoms; provide regular reporting of pain 
scores on interdisciplinary patient care rounds and daily goal sheets; introduce automatic bowel regimen order prompt for a 
patient receiving an opioid
• Address the need for new documentation formats
—e.g., Nurses’ symptom assessments imported into physician electronic progress note template and/or into weekly report for 
interdisciplinary review
• Arrange for targeted education
—e.g., Fast Facts (http://www.eperc.mcw.edu/EPERC/FastFactsandConcepts)
—ELNEC training materials (http://www.aacn.nche.edu/ELNEC/)
—Selected references from IPAL-ICU Reference Library (http://www.capc.org/ipal/ipal-icu/reference-library/pain)
• Plan for evaluation of progress toward specific target and overall goal
—Choose measures and feedback strategy
• Assign responsibility for action steps
—e.g., Dr. X and Nurse Y will develop a bowel regimen, Dr. Y will revise physician documentation template, Nurse Educator 
will train staff for interdisciplinary rounds presentations, Dr. Z and Nurse W will compile data on quality measure
Foster a supportive culture for sustainable change
• Engage the entire interdisciplinary team in regular meetings to discuss
• Initiative’s rationale, plan, and progress
• Identify champions across disciplines
• Deliver feedback constructively, with emphasis on successes
• Make an analogy between inadequate symptom assessment and management and errors compromising patient safety
HCAHPS hospital consumer assessment of healthcare providers and systems, ELNEC end-of-life nursing education consortium
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Table 6
Examples of measures for symptom improvement initiative
Symptom/evaluation Measure Source
Pain assessment Percent of 4-h nurse–patient care intervalsa
in which pain was assessed and
documentedb
ICU Pain Assessment, Agency for Healthcare
Research and Quality—available at
http://www.qualitymeasures.ahrq.gov/content.aspx?
id=28311&search=palliative+care
Pain management Proportion of assessmentsa in which pain
score ≤3 on 0–10 scale
ICU Pain Management, Agency for Healthcare
Research and Quality—available at
http://www.qualitymeasures.ahrq.gov/content.aspx?
id=28312&search=palliative+care
Pain management Proportion of ICU patients responding
usually or always to HCAHPS item 13,
“how often was pain controlled?”
HCAHPS Hospital Survey, pain control
item—available at
http://www.hcahpsonline.org/files/HCAHPS%20V8.0%20Appendix
%20A%20-%20HCAHPS%20Mail%20Survey%20Materials
%20(English)%20March%202013.pdf
Pain management Proportion of ICU patients responding
usually or always to HCAHPS item 14,
“how often did staff do everything they
could to help you with your pain?”
HCAHPS Hospital Survey, staff effort to help
with pain item—available at
http://www.hcahpsonline.org/files/HCAHPS%20V8.0%20Appendix
%20A%20-%20HCAHPS%20Mail%20Survey%20Materials
%20(English)%20March%202013.pdf
Unintended consequences
of pain management:
constipation, respiratory
depression, opioid
tolerance
Bowel movement every day: yes/no
Spontaneous respiratory rate [10: yes/no
Opioid dose: increased within last 24 h
without apparent increase in pain: yes/no
[8]
[109]
Dyspnea assessment Percent of 8-h patient–nurse intervals in
which respiratory distress (for
nonventilated patients) or patient–
ventilator dyssynchrony (for ventilated
patients) was assessed and documented
Respiratory distress assessment—Robert
Wood Johnson Foundation Critical Care
Workgroup [96]
Dyspnea management Treatment or management plan for
respiratory distress (for nonventilated
patients) or patient–ventilator
dyssynchrony (for ventilated patients)
[3 on 0–10 scale
Respiratory distress assessment—Robert
Wood Johnson Foundation Critical Care
Workgroup [96]
a
Maximum 6/day
b
Intervals when patient is not present in the ICU or is asleep are excluded
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